ArticleInternational journal of molecular sciences2021

Anticancer Activity and Mechanisms of Action of New Chimeric EGFR/HDAC-Inhibitors.

Nils Goehringer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.